The cancer landscape has changed for patients with the introduction of targeted therapies, and a combination targeted therapy for some patients with colorectal cancer shows new promise.
Scot Kopetz, M.D., Ph.D., FACP
Advertisement
Articles by Scot Kopetz, M.D., Ph.D., FACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
Phase 3 Trial Shows Adding Imdelltra to First-Line Treatment Helps Patients With SCLC Live Longer
3
Six Years Later, Most Myeloma Patients on a Darzalex Regimen Are Still Progression-Free
4
Beyond Pinktober: What Breast Cancer Awareness Means With Metastatic Breast Cancer
5